Glaukos Corporation Common Stock (NY:GKOS)
181.50
+1.48
(+0.82%)
Streaming Delayed Price
Updated: 12:13 PM EDT, Aug 10, 2026
Add to My Watchlist
All News about Glaukos Corporation Common Stock
Glaukos Submits New Drug Application to U.S. FDA for iDose TR
February 27, 2023
Glaukos Announces Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023
Earnings Preview For Glaukos ↗
February 21, 2023
Analyst Expectations for Glaukos's Future ↗
December 28, 2022
10 Analysts Have This to Say About Glaukos ↗
December 28, 2022
What 10 Analyst Ratings Have To Say About Glaukos ↗
December 28, 2022
7 Analysts Have This to Say About Glaukos ↗
December 12, 2022
Analyst Ratings for Glaukos ↗
December 12, 2022
Glaukos Announces Participation in the Citi Healthcare Conference
February 15, 2023
Where Glaukos Stands With Analysts ↗
December 12, 2022
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
December 28, 2022
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022 ↗
December 22, 2022
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022 ↗
December 19, 2022
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022 ↗
December 12, 2022
Glaukos Corporation Announces Third Quarter 2022 Financial Results
November 02, 2022
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary ↗
September 07, 2022
Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday ↗
September 08, 2022
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.